Dr. Shelby
@shelbynewsad
“the only VC still keeping biotech weird”. partner @compoundVC | writing
3.2K Following 6.2K Followers
small molecule synthesis is stuck decades behind other modalities
@satomic_ai is making it more engineerable to enable abundance and eventually abstraction.
despite small molecule engineering difficulties, they still are 50% of drug approvals and could be more when Satomic increases the scale and speed of synthesis.
Show more
